Mani Reeta Subramaniam, Anand Ashwini Manoor, Madhusudana Shampur Narayan
Department of Neurovirology, National Institute of Mental Health and Neurosciences, WHO Collaborating Centre for Reference and Research on Rabies, Bangalore, India.
Trop Med Int Health. 2016 Apr;21(4):556-63. doi: 10.1111/tmi.12669. Epub 2016 Feb 9.
Rabies, an acute progressive encephalomyelitis, continues to be a serious public health problem in India and many other countries in Asia and Africa. The low level of commitment to rabies control is partly attributable to challenges in laboratory diagnosis and lack of adequate surveillance to indicate the disease burden. A laboratory audit of human rabies cases was undertaken to disseminate information on the clinical, demographic, prophylactic and most importantly the laboratory diagnostic aspects of rabies.
A retrospective analysis of all clinically suspected human rabies cases, whose samples were received at a rabies diagnostic laboratory in South India in the last 3 years, was performed. Clinical and demographic details of patients were obtained. The clinical samples included cerebrospinal fluid (CSF), serum, saliva and nuchal skin biopsy collected antemortem, and brain tissue obtained post-mortem. Various laboratory tests were performed for diagnosis.
Clinical samples from 128 patients with suspected rabies, from 11 states in India, were received for diagnostic confirmation. About 94% of the victims reported dog-bites, more than a third of them were children and most of the victims did not receive adequate post-exposure prophylaxis. Antemortem confirmation of rabies by a combination of laboratory diagnostic assays (detection of viral RNA in CSF, skin and saliva, and neutralising antibodies in CSF) could be achieved in 40.6% cases.
Increasing awareness about adequate post-exposure prophylaxis, additional rabies diagnostic facilities, and enhanced human and animal rabies surveillance to indicate the true disease burden are essential to control this fatal disease.
狂犬病是一种急性进行性脑脊髓炎,在印度以及亚洲和非洲的许多其他国家仍然是一个严重的公共卫生问题。对狂犬病控制的投入水平较低,部分原因是实验室诊断存在挑战,且缺乏足够的监测来表明疾病负担。对人类狂犬病病例进行了实验室审核,以传播有关狂犬病的临床、人口统计学、预防方面,以及最重要的实验室诊断方面的信息。
对过去3年在印度南部一家狂犬病诊断实验室收到样本的所有临床疑似人类狂犬病病例进行回顾性分析。获取了患者的临床和人口统计学详细信息。临床样本包括生前采集的脑脊液(CSF)、血清、唾液和颈部皮肤活检样本,以及死后获得的脑组织。进行了各种实验室检测以进行诊断。
收到了来自印度11个邦的128例疑似狂犬病患者的临床样本进行诊断确认。约94%的受害者报告被狗咬伤,其中超过三分之一是儿童,大多数受害者未接受充分的暴露后预防。通过实验室诊断检测组合(检测脑脊液、皮肤和唾液中的病毒RNA以及脑脊液中的中和抗体)在40.6%的病例中实现了生前狂犬病确诊。
提高对充分暴露后预防的认识、增加狂犬病诊断设施,以及加强人类和动物狂犬病监测以表明真实的疾病负担,对于控制这种致命疾病至关重要。